Assignee
EUCLISES PHARMACEUTICALS INC
US·4 granted patents·3 pending applications·0 citations·filing 2013–2022
Top patents by PatentIndex Score
7 records- 0170US12544356B2Combination of a chromene compound and a second active agentEUCLISES PHARMACEUTICALS INC·Filed 2022·Granted Feb 10, 2026·0 cites·8 claims
- 0258US9044464B2No-releasing guanidine-coxib anti-cancer agentsEUCLISES PHARMACEUTICALS INC·Filed 2013·Granted Jun 2, 2015·0 cites·19 claims
- 0351US2017196835A1Combination of a chromene compound and a second active agentEUCLISES PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0445US8859781B2No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agentsEUCLISES PHARMACEUTICALS INC·Filed 2013·Granted Oct 14, 2014·0 cites·26 claims
- 0539US10266511B2No-releasing nitrooxy-chromene conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Granted Apr 23, 2019·0 cites·6 claims
- 0637US2015197500A1No-releasing guanidine-chromene conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0731US2015197494A1No-releasing nitrooxy-methylene-linked-coxib conjugatesEUCLISES PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →